$Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study$

Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study

Bibliographic Details
Main Authors:	Yan-Yan Li, Shuai-Shuai Ge, Yuan-Hong Huang, Ming-Zhu Xu, Chao-Ling Wan, Kai-Wen Tan, Tao Tao, Hai-Xia Zhou, Sheng-Li Xue, Hai-Ping Dai
Format:	Article
Language:	English
Published:	Nature Publishing Group 2024-01-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-024-00982-3

Internet